Editorial

22 August 2022

Editorial: Disease modifying therapies in multiple sclerosis

Simona Bonavita

Mahsa Ghajarzadeh

and

Luigi Lavorgna

2,036 views

0 citations

Editors

Mahsa Ghajarzadeh

Johns Hopkins Medicine, Johns Hopkins University

Simona Bonavita

University of Campania Luigi Vanvitelli

Luigi Lavorgna

University of Campania Luigi Vanvitelli

Impact

Original Research

06 June 2022

Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration In Vitro Acutely Influences Monocyte Differentiation but Not Microglial Activation

Tiago Medeiros-Furquim

, 5 more and

Trevor J. Kilpatrick

7,094 views

3 citations

Case Report

08 December 2021

Opportunities and Obstacles Associated With Sequential Immune Reconstitution Therapy for Multiple Sclerosis: A Case Report

Riccardo Garbo

, 4 more and

Mariarosaria Valente

1,940 views

3 citations

Policy and Practice Reviews

21 October 2021

Clinical Pathway for the Diagnosis and Management of Patients With Relapsing–Remitting Multiple Sclerosis: A First Proposal for the Peruvian Population

César Caparó-Zamalloa

, 6 more and

Carlos Alva-Díaz

3,475 views

3 citations

Case Report

20 October 2021

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series

Stefania F. De Mercanti

, 5 more and

Paola Cavalla

5,192 views

1 citations

Original Research

07 September 2021

Silybin Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Dendritic Cell Activation and Th17 Cell Differentiation

Huan-Li Yang

and

Xiao-Wu Shi

2,896 views

10 citations

Original Research

01 September 2021

The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical Utility

Lorena Lorefice

, 7 more and

Eleonora Cocco

3,755 views

3 citations

Original Research

26 August 2021

Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate

Maria C. Buscarinu

, 16 more and

Giovanni Ristori

3,439 views

6 citations

Original Research

23 August 2021

Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center

Marina Boziki

, 10 more and

Nikolaos Grigoriadis

4,262 views

11 citations

Review

20 August 2021

The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations

Maedeh Radandish

, 1 more and

Nafiseh Esmaeil

5,801 views

25 citations

Original Research

05 August 2021

Alemtuzumab in a Large Real-Life Cohort: Interim Baseline Data of the TREAT-MS Study

Tjalf Ziemssen

, 3 more and

Robin White

4,969 views

9 citations

Review

28 July 2021

Review: The Nutritional Management of Multiple Sclerosis With Propionate

Derek Tobin

, 1 more and

Philip C. Calder

7,420 views

16 citations

Case Report

21 July 2021

Dynamic Changes in AQP4-IgG Level and Immunological Markers During Protein-A Immunoadsorption Therapy for NMOSD: A Case Report and Literature Review

Bo Chen

, 6 more and

Dai-Shi Tian

3,357 views

8 citations

Review

06 July 2021

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?

Serena Brancati

, 3 more and

Filippo Drago

26,462 views

49 citations

Review

01 July 2021

Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies

Isabella Laura Simone

, 1 more and

Alma Ghirelli

12,043 views

27 citations

Original Research

17 June 2021

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

Cecilia Smith Simonsen

, 5 more and

Elisabeth Gulowsen Celius

21,391 views

70 citations

Clinical Trial

31 May 2021

Long-Term Clinical and Immunological Effects of Repeated Mesenchymal Stem Cell Injections in Patients With Progressive Forms of Multiple Sclerosis

Panayiota Petrou

, 5 more and

Dimitrios Karussis

6,873 views

32 citations

Original Research

25 May 2021

Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment

Priyanka Devi-Marulkar

, 10 more and

Frédérique Michel

4,388 views

3 citations

Mini Review

17 May 2021

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities

Monica Margoni

, 2 more and

Paolo Gallo

7,811 views

24 citations

Original Research

03 May 2021

Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis

Ulaş Ceylan

, 5 more and

Simon Faissner

4,714 views

23 citations

Fetching...

Home Frontiers in Neurology…Multiple Sclerosis and Neuroimmunology…Research Topics

Enjoyed this Research Topic?

Share it using

Disease Modifying Therapies in Multiple Sclerosis

147.5K

views

167

authors

articles